BIOGEN INC. Stockholders' Equity Attributable to Noncontrolling Interest
BIOGEN INC. (BIIB) had Stockholders' Equity Attributable to Noncontrolling Interest of $0 as of 2023-12-31, per its 10-K filed 2024-02-14.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:MinorityInterest · last filed 2024-02-14
- 2023-12-31: Stockholders' Equity Attributable to Noncontrolling Interest $0.00.
- 2023-09-30: Stockholders' Equity Attributable to Noncontrolling Interest -$4.10M.
- 2023-06-30: Stockholders' Equity Attributable to Noncontrolling Interest -$6.40M.
- 2023-03-31: Stockholders' Equity Attributable to Noncontrolling Interest -$9.60M.
| Period end | Stockholders' Equity Attributable to Noncontrolling Interest | Stockholders' Equity Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2023-12-31 | $0.00 10-K · filed 2024-02-14 | |
| 2023-09-30 | -$4.10M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | -$6.40M 10-Q · filed 2023-07-25 | |
| 2023-03-31 | -$9.60M 10-Q · filed 2023-04-25 | |
| 2022-12-31 | -$9.50M 10-K · filed 2024-02-14 | |
| 2022-09-30 | -$8.70M 10-Q · filed 2022-10-25 | |
| 2022-06-30 | -$9.10M 10-Q · filed 2022-07-20 | |
| 2022-03-31 | -$21.60M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $63.50M 10-K · filed 2023-02-15 | |
| 2021-09-30 | $451.80M 10-Q · filed 2021-10-20 | |
| 2021-06-30 | $462.90M 10-Q · filed 2021-07-22 | |
| 2021-03-31 | -$19.00M 10-Q · filed 2021-04-22 | |
| 2020-12-31 | -$14.20M 10-K · filed 2022-02-03 | |
| 2020-09-30 | -$14.00M 10-Q · filed 2020-10-21 | |
| 2020-06-30 | -$19.50M 10-Q · filed 2020-07-22 | |
| 2020-03-31 | -$10.00M 10-Q · filed 2020-04-23 | |
| 2019-12-31 | -$4.10M 10-K · filed 2021-02-03 | |
| 2019-09-30 | -$4.10M 10-Q · filed 2019-10-22 | |
| 2019-06-30 | -$4.10M 10-Q · filed 2019-07-24 | |
| 2019-03-31 | -$7.90M 10-Q · filed 2019-04-24 | |
| 2018-12-31 | -$8.00M 10-K · filed 2020-02-06 | |
| 2018-09-30 | -$6.80M 10-Q · filed 2018-10-23 | |
| 2018-06-30 | -$7.20M 10-Q · filed 2018-10-23 | |
| 2018-03-31 | -$16.20M 10-Q · filed 2018-07-24 | |
| 2017-12-31 | -$14.70M 10-K · filed 2019-02-06 | |
| 2017-09-30 | -$11.60M 10-Q · filed 2018-10-23 | |
| 2017-06-30 | -$11.60M 10-Q · filed 2018-10-23 | |
| 2017-03-31 | -$11.60M 10-Q · filed 2018-07-24 | |
| 2016-12-31 | -$11.50M 10-Q · filed 2018-10-23 | |
| 2016-09-30 | -$2.70M 10-Q · filed 2017-10-24 | |
| 2016-06-30 | -$100.00K 10-Q · filed 2017-10-24 | |
| 2016-03-31 | $1.30M 10-Q · filed 2017-07-25 | |
| 2015-12-31 | $2.10M 10-Q · filed 2017-10-24 | |
| 2015-09-30 | -$5.80M 10-Q · filed 2016-10-26 | -$5.78M 10-Q · filed 2015-10-21 |
| 2015-06-30 | $400.00K 10-Q · filed 2016-10-26 | $421.00K 10-Q · filed 2015-07-24 |
| 2015-03-31 | $2.70M 10-Q · filed 2016-07-21 | $2.69M 10-Q · filed 2015-04-24 |
| 2014-12-31 | $5.00M 10-Q · filed 2016-10-26 | $5.03M 10-K · filed 2015-02-04 |
| 2014-09-30 | $3.20M 10-Q · filed 2015-10-21 | $3.19M 10-Q · filed 2014-10-22 |
| 2014-06-30 | $3.90M 10-Q · filed 2015-10-21 | $3.93M 10-Q · filed 2014-07-23 |
| 2014-03-31 | $4.40M 10-Q · filed 2015-07-24 | $4.35M 10-Q · filed 2014-04-23 |
| 2013-12-31 | $600.00K 10-Q · filed 2015-10-21 | $596.00K 10-K · filed 2014-02-06 |
| 2013-09-30 | $600.00K 10-Q · filed 2014-10-22 | $596.00K 10-Q · filed 2013-10-28 |
| 2013-06-30 | $600.00K 10-Q · filed 2014-10-22 | $596.00K 10-Q · filed 2013-07-25 |
| 2013-03-31 | $600.00K 10-Q · filed 2014-07-23 | $596.00K 10-Q · filed 2013-04-25 |
| 2012-12-31 | $2.30M 10-Q · filed 2014-10-22 | $2.27M 10-K · filed 2013-02-05 |
| 2012-09-30 | $2.40M 10-Q · filed 2013-10-28 | $2.39M 10-Q · filed 2012-10-25 |
| 2012-06-30 | $2.40M 10-Q · filed 2013-07-25 | $2.39M 10-Q · filed 2012-07-24 |
| 2012-03-31 | $2.40M 10-Q · filed 2013-10-28 | $2.65M 10-Q · filed 2012-05-01 |
| 2011-12-31 | $1.50M 10-Q · filed 2013-10-28 | $1.49M 10-K · filed 2012-02-03 |
| 2011-09-30 | $4.40M 10-Q · filed 2012-10-25 | $4.45M 10-Q · filed 2011-10-28 |
| 2011-06-30 | $79.10M 10-Q · filed 2012-10-25 | $79.14M 10-Q · filed 2011-07-26 |
| 2011-03-31 | $70.10M 10-Q · filed 2012-07-24 | $70.14M 10-Q · filed 2011-04-21 |
| 2010-12-31 | $52.90M 10-Q · filed 2012-10-25 | $52.94M 10-K · filed 2011-02-04 |
| 2010-09-30 | $39.50M 10-Q · filed 2011-10-28 | $39.51M 10-Q · filed 2010-10-26 |
| 2010-06-30 | $40.50M 10-Q · filed 2011-10-28 | $40.48M 10-Q · filed 2010-07-20 |
| 2010-03-31 | $41.20M 10-Q · filed 2011-07-26 | $41.22M 10-Q · filed 2010-04-20 |
| 2009-12-31 | $40.40M 10-Q · filed 2011-10-28 | $40.35M 10-K · filed 2010-02-09 |
| 2009-09-30 | $33.60M 10-Q · filed 2010-10-26 | $33.62M 10-Q · filed 2009-10-21 |
| 2009-06-30 | $33.20M 10-Q · filed 2010-10-26 | |
| 2009-03-31 | $32.60M 10-Q · filed 2010-07-20 | |
| 2008-12-31 | $27.90M 10-Q · filed 2010-10-26 | $27.87M 10-Q · filed 2009-10-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |